Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The Plasmodium falciparum mosquito challenge is a standardized experimental procedure used to induce malaria infection in healthy volunteers under controlled conditions. It involves the bites of *Anopheles* mosquitoes infected with *Plasmodium falciparum* sporozoites, typically the NF54 strain. This model, extensively utilized and refined by Radboud University Medical Center, serves as a critical tool for evaluating the efficacy of malaria vaccine candidates and prophylactic drugs. In the context of the 'CPS' (Chloroquine Prophylaxis and Sporozoites) immunization strategy, volunteers are exposed to these infected mosquito bites while under chloroquine prophylaxis. This allows the parasite to complete its liver-stage development but prevents symptomatic blood-stage infection, thereby inducing potent, long-lasting protective immunity against subsequent challenges.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Plasmodium falciparum mosquito challenge.